| 30.0 |
90.0 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 17.1 |
85.7 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 15.9 |
95.6 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 15.5 |
62.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 13.4 |
40.3 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 13.3 |
120.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 12.3 |
74.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 12.2 |
61.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 11.6 |
58.1 |
GO:0021856 |
cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
| 11.0 |
121.4 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 10.6 |
170.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 10.2 |
81.7 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 9.4 |
84.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 9.3 |
46.3 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 9.2 |
55.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 8.9 |
44.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 7.7 |
23.2 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 7.5 |
52.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 7.5 |
29.9 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 7.5 |
37.3 |
GO:0032763 |
regulation of mast cell cytokine production(GO:0032763) |
| 7.4 |
22.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 7.3 |
21.8 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) noradrenergic neuron differentiation(GO:0003357) |
| 7.2 |
94.0 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 7.0 |
28.0 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 7.0 |
20.9 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 6.8 |
27.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 6.5 |
26.0 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 6.3 |
25.3 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 5.9 |
65.0 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 5.9 |
23.6 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 5.7 |
17.1 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 5.7 |
34.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 5.7 |
238.7 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 5.5 |
49.8 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 5.5 |
16.4 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 5.4 |
54.3 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 5.4 |
16.2 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 5.1 |
66.9 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
| 5.1 |
10.3 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
| 5.1 |
164.0 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 5.0 |
20.1 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
| 5.0 |
34.9 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 4.9 |
19.7 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 4.9 |
73.7 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 4.8 |
23.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 4.8 |
38.1 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 4.7 |
14.2 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 4.7 |
33.0 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 4.7 |
61.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 4.6 |
13.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 4.6 |
13.7 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 4.5 |
99.7 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 4.5 |
22.5 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 4.4 |
30.6 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 4.1 |
8.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 4.0 |
16.0 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 3.9 |
15.7 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 3.9 |
31.3 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 3.9 |
15.6 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 3.9 |
50.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 3.8 |
23.0 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 3.7 |
3.7 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 3.6 |
50.9 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 3.6 |
14.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 3.6 |
7.2 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 3.6 |
17.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 3.5 |
35.5 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 3.4 |
13.7 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 3.4 |
13.6 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 3.3 |
106.6 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 3.3 |
9.8 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 3.3 |
39.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 3.1 |
21.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 3.1 |
18.6 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 3.1 |
40.0 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 3.0 |
18.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 3.0 |
15.0 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 2.9 |
17.7 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 2.9 |
38.2 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 2.8 |
14.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 2.8 |
101.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 2.7 |
19.1 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 2.7 |
8.1 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 2.7 |
8.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 2.7 |
10.6 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 2.6 |
5.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.6 |
10.3 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 2.6 |
18.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.6 |
25.8 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 2.5 |
15.0 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 2.4 |
7.1 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 2.4 |
42.5 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 2.3 |
4.7 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 2.3 |
37.3 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 2.3 |
9.0 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 2.3 |
51.8 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 2.3 |
4.5 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 2.2 |
6.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 2.2 |
6.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 2.2 |
6.5 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 2.2 |
10.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.1 |
10.7 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 2.1 |
6.4 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 2.1 |
32.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 2.1 |
17.2 |
GO:1903421 |
regulation of synaptic vesicle recycling(GO:1903421) |
| 2.1 |
8.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 2.1 |
8.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 2.1 |
29.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 2.1 |
6.2 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 2.1 |
14.5 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 2.1 |
12.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 2.0 |
6.0 |
GO:0051934 |
positive regulation of neurotransmitter uptake(GO:0051582) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 2.0 |
11.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 1.9 |
7.8 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 1.9 |
30.9 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 1.9 |
5.6 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 1.8 |
46.2 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 1.8 |
62.7 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 1.8 |
9.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.8 |
14.4 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 1.8 |
7.2 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of receptor catabolic process(GO:2000645) |
| 1.8 |
19.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 1.8 |
7.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 1.8 |
7.0 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.7 |
10.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 1.7 |
8.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 1.6 |
24.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 1.6 |
26.1 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 1.6 |
9.7 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 1.6 |
24.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 1.6 |
12.4 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 1.5 |
4.6 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 1.5 |
12.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 1.5 |
5.9 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) regulation of glutamate metabolic process(GO:2000211) |
| 1.5 |
5.9 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 1.5 |
26.1 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 1.4 |
2.8 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 1.4 |
52.0 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 1.4 |
61.6 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 1.4 |
5.4 |
GO:0072362 |
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
| 1.3 |
5.4 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 1.3 |
9.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 1.3 |
14.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.3 |
3.9 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 1.3 |
3.9 |
GO:0010881 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 1.3 |
3.9 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 1.3 |
6.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 1.2 |
53.1 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 1.2 |
22.7 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 1.2 |
93.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 1.2 |
10.6 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 1.2 |
7.0 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 1.2 |
11.6 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 1.1 |
65.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 1.1 |
6.7 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 1.1 |
6.7 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.1 |
2.2 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 1.1 |
8.8 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 1.1 |
9.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 1.1 |
21.7 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 1.1 |
5.3 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 1.1 |
2.1 |
GO:2000822 |
regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
| 1.0 |
7.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 1.0 |
62.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 1.0 |
2.0 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 1.0 |
6.0 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 1.0 |
4.0 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 1.0 |
3.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 1.0 |
4.9 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 1.0 |
1.9 |
GO:1904395 |
retinal rod cell differentiation(GO:0060221) positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) positive regulation of neuromuscular junction development(GO:1904398) |
| 1.0 |
5.8 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.0 |
5.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 1.0 |
4.8 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.9 |
2.8 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.9 |
37.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.9 |
38.2 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.9 |
3.6 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.9 |
80.0 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.9 |
2.7 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.9 |
2.6 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.8 |
3.4 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.8 |
3.3 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.8 |
10.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.8 |
2.5 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.8 |
4.1 |
GO:0071635 |
negative regulation of transforming growth factor beta production(GO:0071635) |
| 0.8 |
8.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.8 |
7.3 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.8 |
4.0 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.8 |
10.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.8 |
2.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 |
12.4 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.8 |
4.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.8 |
3.0 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.8 |
2.3 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.8 |
5.3 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.7 |
12.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.7 |
2.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.7 |
21.5 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
| 0.7 |
4.8 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.7 |
12.8 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.7 |
0.7 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.7 |
8.7 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.7 |
2.7 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.7 |
2.6 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.6 |
3.2 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.6 |
2.6 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.6 |
6.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.6 |
5.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.6 |
4.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.6 |
3.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.6 |
3.5 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.6 |
17.5 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.6 |
2.9 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.6 |
5.2 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.6 |
5.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.6 |
7.4 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.6 |
4.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.6 |
2.3 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.6 |
1.1 |
GO:0044860 |
protein localization to plasma membrane raft(GO:0044860) |
| 0.6 |
14.6 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.6 |
38.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.6 |
6.6 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 |
6.0 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.5 |
13.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.5 |
5.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.5 |
3.8 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.5 |
4.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.5 |
28.8 |
GO:0007612 |
learning(GO:0007612) |
| 0.5 |
4.1 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.5 |
5.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.5 |
1.5 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.5 |
17.1 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.5 |
1.5 |
GO:0060126 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) somatotropin secreting cell differentiation(GO:0060126) |
| 0.5 |
1.5 |
GO:0006586 |
tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.5 |
1.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.5 |
1.4 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.5 |
2.9 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.5 |
1.9 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.5 |
8.0 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.5 |
1.9 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 |
7.9 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.5 |
2.8 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.5 |
3.2 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.5 |
2.7 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.5 |
9.9 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.4 |
10.3 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
6.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.4 |
3.9 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.4 |
0.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.4 |
2.1 |
GO:0036438 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) maintenance of lens transparency(GO:0036438) |
| 0.4 |
3.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.4 |
2.1 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.4 |
2.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.4 |
19.7 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.4 |
2.8 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
3.6 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.4 |
4.7 |
GO:0001783 |
B cell apoptotic process(GO:0001783) |
| 0.4 |
1.6 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.4 |
2.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.4 |
7.5 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.4 |
2.6 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.4 |
3.0 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.4 |
1.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.4 |
6.3 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 |
3.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.4 |
1.8 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 |
0.4 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.4 |
2.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.4 |
1.4 |
GO:0052490 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) response to cycloheximide(GO:0046898) modulation by symbiont of host programmed cell death(GO:0052040) negative regulation by symbiont of host programmed cell death(GO:0052041) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.4 |
15.9 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
3.0 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.3 |
1.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.3 |
18.6 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.3 |
3.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.3 |
1.6 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 |
3.9 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.3 |
1.5 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.3 |
9.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
6.7 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
28.4 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.3 |
1.4 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.3 |
1.4 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.3 |
1.4 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 |
2.8 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
0.5 |
GO:0060745 |
prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) mammary gland branching involved in pregnancy(GO:0060745) |
| 0.3 |
1.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 |
1.3 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.3 |
0.8 |
GO:0090069 |
regulation of ribosome biogenesis(GO:0090069) |
| 0.3 |
1.8 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.3 |
2.3 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.3 |
2.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.3 |
1.0 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 |
6.6 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.3 |
24.1 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.3 |
2.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.5 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 |
0.2 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.7 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.2 |
0.7 |
GO:0032930 |
positive regulation of superoxide anion generation(GO:0032930) |
| 0.2 |
1.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
0.5 |
GO:1901419 |
vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) cellular response to vitamin D(GO:0071305) regulation of response to alcohol(GO:1901419) |
| 0.2 |
5.3 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.2 |
12.4 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.2 |
0.7 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
3.8 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.2 |
1.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
1.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
1.5 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
4.3 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.2 |
1.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
0.8 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.2 |
7.3 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.2 |
9.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
1.4 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 |
4.7 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
0.4 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.2 |
4.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.2 |
6.2 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.2 |
1.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
2.0 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
6.8 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.2 |
1.6 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
2.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.2 |
2.6 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
1.1 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
1.6 |
GO:0031272 |
regulation of pseudopodium assembly(GO:0031272) |
| 0.2 |
1.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
1.0 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.2 |
0.7 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) specification of axis polarity(GO:0065001) |
| 0.2 |
0.5 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
0.2 |
GO:0045852 |
pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
| 0.2 |
1.9 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.2 |
1.8 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.2 |
0.8 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
1.8 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.2 |
1.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
11.9 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
3.0 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
10.5 |
GO:0031929 |
TOR signaling(GO:0031929) |
| 0.1 |
0.9 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
2.5 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
1.0 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
1.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
4.1 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 |
1.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.8 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) establishment of mitotic spindle localization(GO:0040001) |
| 0.1 |
0.8 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
0.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.5 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
1.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
1.7 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
1.8 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 |
0.6 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
3.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
1.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.8 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
1.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 |
7.7 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.1 |
1.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
3.3 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.1 |
1.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.7 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.6 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
0.8 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.4 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.1 |
0.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.7 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.7 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.9 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
0.7 |
GO:0070131 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) positive regulation of mitochondrial translation(GO:0070131) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
6.4 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.6 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
0.6 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.5 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
2.8 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.1 |
0.3 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
3.0 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
1.4 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
2.6 |
GO:0050770 |
regulation of axonogenesis(GO:0050770) |
| 0.0 |
0.3 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.9 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
1.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
1.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.0 |
0.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
2.5 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.4 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) taurine metabolic process(GO:0019530) |
| 0.0 |
0.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.0 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
1.3 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.5 |
GO:0017015 |
regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
